{"type":"rich","version":"1.0","title":"More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens  – Tech in Two.","author_name":"What's New With WIRED","author_url":"https://omny.fm/shows/whats-new-with-wired","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/whats-new-with-wired/more-vaccines-enter-phase-iii-trials-researchers-a/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens  – Tech in Two.\"></iframe>","width":600,"height":180}